Soligenix (SNGX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov8

Soligenix released FY2025 9 Months Earnings on November 7, 2025 (EST), actual revenue USD 0, actual EPS USD -2.47

04:00

Soligenix released FY2025 Q3 earnings on November 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5845 (forecast USD -0.63)

04:00

Nov4

Soligenix Inc Expected to Report Flat Quarterly Revenue

14:11

Sep30

Soligenix Expands European Medical Advisory Board to Advance HyBryte Clinical Trials

11:30

Sep4

Soligenix Inc Publishes Article on High-Temperature Stability of Ebola and Related Viral Protein Subunit Vaccine

14:59

Aug15

Soligenix released FY2025 Semi-Annual Earnings on August 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.7862

03:00

Schedules & Filings

Schedules

Filings

Nov7

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.531 M, EPS -0.5845

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.702 M, EPS -0.8241

May9

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.237 M, EPS -1.0613

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More